公开(公告)号：US20240226403A1

公开(公告)日：2024-07-11

申请号：US18561569

申请日：2022-04-12

Applicant: KANEKA CORPORATION ,  Broad Bean Science Co., LTD.

Inventor： Yuta FUJITA ,  Makoto KUROO

IPC: A61M1/36 ,  A61K35/14 ,  A61P7/08

CPC classification number: A61M1/3633 ,  A61K35/14 ,  A61P7/08 ,  A61M2202/0413

Abstract: The objective of the present invention is to provide a treatment material for the treatment of a disease of which symptom is alleviated or treated by reducing a blood phosphorus concentration. The treatment material according to the present invention is characterized in comprising a water-insoluble carrier and 1 or more adsorbing groups selected from the group consisting of a phosphate group, a phosphonate group, a phosphinate group, an amino group, a carboxy group and a thiol group, wherein the adsorbing group binds to the water-insoluble carrier through a linker group, the treatment material is used for treating a disease, wherein a symptom of the disease is alleviated or treated by reducing a blood phosphorus concentration, and dialyzed blood is passed through the treatment material to adsorb a calciprotein particle in the dialyzed blood on the adsorbing group, or blood is passed through the treatment material and then dialyzed.